Almirall Hermal GmbH

Industry / private company


Location: Reinbek, Germany (DE) DE

ISNI: 0000000405516030

ROR: https://ror.org/04v3pva14

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Real-world evidence of tirbanibulin in the treatment of actinic keratosis in Germany – prospective, multicenter, non-interventional KLIR study (2025) Heppt M, Hadshiew I, Kempf A, Melzer A, Berking C Journal article CHALLENGES OF NETWORK META-ANALYSIS FOR SAFETY OUTCOMES: THE ANALYSIS OF TIRBANIBULIN AGAINST COMMON TREATMENTS IN EUROPE FOR ACTINIC KERATOSIS (2022) Heppt M, Dykukha I, Chapman-Rounds M, Graziadio S, Edwards M Conference contribution ASSESSING SIMILARITY OF STUDIES FOR NETWORK META-ANALYSIS: THE USE OF FEASIBILITY ASSESSMENT AND SENSITIVITY ANALYSES TO ESTIMATE THE EFFICACY OF TIRBANIBULIN, A NEW DRUG FOR ACTINIC KERATOSIS (2022) Heppt M, Dykukha , Chapman-Rounds M, Graziadio S, Edwards M Conference contribution Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (2022) Heppt M, Dykukha I, Graziadio S, Salido-Vallejo R, Chapman-Rounds M, Edwards M Journal article, Review article A novel antiproliferative, pro-apoptotic Approach for the Treatment of actinic Keratoses: Tirbanibulin (KX2-391) (2021) Heppt M, Ocker WG, Melzer A Conference contribution